TheChineTime

Eli Lilly to invest $3bn in China in anticipation of orforglipron approval - Pharmaceutical Technology

2026-03-11 - 15:43

Eli Lilly to invest $3bn in China in anticipation of orforglipron approval Pharmaceutical Technology

Share this post: